| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Mediator_Med25 | 1.38e-05 | 2 | 70 | 2 | IPR021394 | |
| Domain | Med25 | 1.38e-05 | 2 | 70 | 2 | PF11232 | |
| Domain | VGCC_alpha2 | 8.27e-05 | 4 | 70 | 2 | PF08473 | |
| Domain | VDCC_a2/dsu | 8.27e-05 | 4 | 70 | 2 | IPR013680 | |
| Domain | P5-ATPase | 8.27e-05 | 4 | 70 | 2 | PF12409 | |
| Domain | VWA_N | 1.37e-04 | 5 | 70 | 2 | IPR013608 | |
| Domain | VWA_N | 1.37e-04 | 5 | 70 | 2 | PF08399 | |
| Domain | P-type_TPase_V | 1.37e-04 | 5 | 70 | 2 | IPR006544 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.58e-04 | 37 | 70 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.58e-04 | 37 | 70 | 3 | PF00122 | |
| Domain | VWF_A | 5.21e-04 | 99 | 70 | 4 | IPR002035 | |
| Domain | VWA | 1.21e-03 | 56 | 70 | 3 | PF00092 | |
| Domain | Cation_ATPase_N | 2.04e-03 | 18 | 70 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 2.04e-03 | 18 | 70 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.27e-03 | 19 | 70 | 2 | IPR004014 | |
| Domain | UDPGT | 2.78e-03 | 21 | 70 | 2 | PF00201 | |
| Domain | UDPGT | 2.78e-03 | 21 | 70 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 2.78e-03 | 21 | 70 | 2 | IPR002213 | |
| Domain | VWFA | 3.61e-03 | 82 | 70 | 3 | PS50234 | |
| Domain | VWA | 3.87e-03 | 84 | 70 | 3 | SM00327 | |
| Domain | HormR | 3.93e-03 | 25 | 70 | 2 | SM00008 | |
| Domain | HRM | 4.91e-03 | 28 | 70 | 2 | PF02793 | |
| Domain | Alkaline_phosphatase_core | 6.00e-03 | 31 | 70 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 6.00e-03 | 31 | 70 | 2 | IPR017849 | |
| Domain | - | 6.00e-03 | 31 | 70 | 2 | 3.40.720.10 | |
| Domain | - | 6.39e-03 | 32 | 70 | 2 | 3.40.1110.10 | |
| Domain | - | 6.39e-03 | 32 | 70 | 2 | 2.70.150.10 | |
| Domain | LRR | 6.86e-03 | 201 | 70 | 4 | PS51450 | |
| Domain | GPCR_2_secretin-like_CS | 7.19e-03 | 34 | 70 | 2 | IPR017983 | |
| Domain | ATPase_P-typ_cyto_domN | 7.61e-03 | 35 | 70 | 2 | IPR023299 | |
| Domain | P_typ_ATPase | 8.03e-03 | 36 | 70 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 8.03e-03 | 36 | 70 | 2 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 8.03e-03 | 36 | 70 | 2 | PS00154 | |
| Domain | LRR_1 | 9.22e-03 | 219 | 70 | 4 | PF00560 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 9.85e-03 | 40 | 70 | 2 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 9.85e-03 | 40 | 70 | 2 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 9.85e-03 | 40 | 70 | 2 | PS50227 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 21110951 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 15925480 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 33297767 | ||
| Pubmed | Presynaptic α2δ subunits are key organizers of glutamatergic synapses. | 1.37e-05 | 3 | 75 | 2 | 33782113 | |
| Pubmed | Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. | 1.37e-05 | 3 | 75 | 2 | 21262827 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 20080692 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 15236333 | ||
| Pubmed | 2.01e-05 | 152 | 75 | 5 | 19578796 | ||
| Pubmed | EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes. | 2.75e-05 | 4 | 75 | 2 | 18806884 | |
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 2.75e-05 | 4 | 75 | 2 | 18223459 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 19596051 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 21193198 | ||
| Pubmed | Engineering an inhibitor-resistant human CSF1R variant for microglia replacement. | 4.57e-05 | 5 | 75 | 2 | 36584406 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 30352428 | ||
| Pubmed | Parkinson disease related ATP13A2 evolved early in animal evolution. | 4.57e-05 | 5 | 75 | 2 | 29505581 | |
| Pubmed | Characterization of the P5 subfamily of P-type transport ATPases in mice. | 4.57e-05 | 5 | 75 | 2 | 15381061 | |
| Pubmed | Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. | 4.57e-05 | 5 | 75 | 2 | 25561180 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 23477738 | ||
| Pubmed | Development and function of human innate immune cells in a humanized mouse model. | 6.84e-05 | 6 | 75 | 2 | 24633240 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 30504915 | ||
| Pubmed | Development of a Chimeric Model to Study and Manipulate Human Microglia In Vivo. | 6.84e-05 | 6 | 75 | 2 | 31375314 | |
| Pubmed | iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases. | 6.84e-05 | 6 | 75 | 2 | 28426964 | |
| Pubmed | The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. | 6.84e-05 | 6 | 75 | 2 | 28606987 | |
| Pubmed | inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice. | 6.84e-05 | 6 | 75 | 2 | 27581357 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 30683685 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 28591638 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 30664659 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 9.57e-05 | 7 | 75 | 2 | 8467709 | |
| Pubmed | Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice. | 9.57e-05 | 7 | 75 | 2 | 27723723 | |
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 33097708 | ||
| Pubmed | Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis. | 1.27e-04 | 8 | 75 | 2 | 37957324 | |
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 22511988 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 1339448 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 15128825 | ||
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 23642732 | ||
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 11465080 | ||
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 31515941 | ||
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.04e-04 | 10 | 75 | 2 | 22558097 | |
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 37550517 | ||
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 19008959 | ||
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.99e-04 | 12 | 75 | 2 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 3.52e-04 | 13 | 75 | 2 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 3.52e-04 | 13 | 75 | 2 | 25246029 | |
| Pubmed | 3.65e-04 | 64 | 75 | 3 | 19729601 | ||
| Pubmed | 4.11e-04 | 14 | 75 | 2 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 4.11e-04 | 14 | 75 | 2 | 10836148 | |
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 4.11e-04 | 14 | 75 | 2 | 17641689 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.11e-04 | 14 | 75 | 2 | 14672974 | |
| Pubmed | 4.11e-04 | 14 | 75 | 2 | 36630911 | ||
| Pubmed | 4.11e-04 | 14 | 75 | 2 | 9295054 | ||
| Pubmed | 4.73e-04 | 15 | 75 | 2 | 20188150 | ||
| Pubmed | 4.73e-04 | 15 | 75 | 2 | 24453333 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 5.40e-04 | 16 | 75 | 2 | 19414484 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 5.40e-04 | 307 | 75 | 5 | 37499664 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 6.11e-04 | 17 | 75 | 2 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 7.66e-04 | 19 | 75 | 2 | 23281178 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 7.69e-04 | 697 | 75 | 7 | 28298427 | |
| Pubmed | A systematic meta-analysis of genetic association studies for diabetic retinopathy. | 8.50e-04 | 20 | 75 | 2 | 19587357 | |
| Pubmed | 9.38e-04 | 200 | 75 | 4 | 18240029 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.85e-04 | 351 | 75 | 5 | 38297188 | |
| Pubmed | Polymorphisms in innate immunity genes and risk of childhood leukemia. | 1.05e-03 | 206 | 75 | 4 | 20438785 | |
| Pubmed | Risk of meningioma and common variation in genes related to innate immunity. | 1.06e-03 | 207 | 75 | 4 | 20406964 | |
| Pubmed | Common variation in genes related to innate immunity and risk of adult glioma. | 1.08e-03 | 208 | 75 | 4 | 19423540 | |
| Pubmed | Charcot-Marie-Tooth Neuropathy Type 2 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 1.13e-03 | 23 | 75 | 2 | 20301462 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.14e-03 | 211 | 75 | 4 | 24097068 | |
| Pubmed | 1.16e-03 | 212 | 75 | 4 | 19521566 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.23e-03 | 24 | 75 | 2 | 24625756 | |
| Pubmed | 1.42e-03 | 102 | 75 | 3 | 9734811 | ||
| Pubmed | 2.05e-03 | 116 | 75 | 3 | 30804394 | ||
| Cytoband | 2q37 | 1.82e-05 | 31 | 75 | 3 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 1.42e-03 | 503 | 75 | 5 | chr6p21 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 7.76e-05 | 5 | 51 | 2 | 1213 | |
| GeneFamily | Glucagon receptor family | 1.16e-04 | 6 | 51 | 2 | 269 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.43e-03 | 26 | 51 | 2 | 253 | |
| GeneFamily | UDP glucuronosyltransferases | 3.67e-03 | 32 | 51 | 2 | 363 | |
| GeneFamily | Olfactory receptors, family 5 | 3.88e-03 | 112 | 51 | 3 | 152 | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 3.32e-05 | 4 | 70 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 3.32e-05 | 4 | 70 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | X-11793--oxidized bilirubin measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.98e-04 | 9 | 70 | 2 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0020691 | |
| Disease | X-21448 measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0802185 | |
| Disease | X-23974 measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 2.47e-04 | 10 | 70 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0800825 | |
| Disease | pregnenetriol sulfate measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0800972 | |
| Disease | aldosterone measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0010219 | |
| Disease | biliverdin measurement | 3.61e-04 | 12 | 70 | 2 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 3.61e-04 | 12 | 70 | 2 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 4.25e-04 | 13 | 70 | 2 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 4.25e-04 | 13 | 70 | 2 | EFO_0800587 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 4.96e-04 | 14 | 70 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | Coronary Arteriosclerosis | 5.03e-04 | 65 | 70 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 5.03e-04 | 65 | 70 | 3 | C1956346 | |
| Disease | X-21441 measurement | 7.37e-04 | 17 | 70 | 2 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 7.37e-04 | 17 | 70 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 8.28e-04 | 18 | 70 | 2 | EFO_0801382 | |
| Disease | diet measurement, body mass index | 1.03e-03 | 20 | 70 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | tissue factor measurement | 1.13e-03 | 21 | 70 | 2 | EFO_0010623 | |
| Disease | myeloperoxidase (MPO)-DNA complex measurement | 1.24e-03 | 22 | 70 | 2 | EFO_0011039 | |
| Disease | Ischemia | 2.02e-03 | 28 | 70 | 2 | C0022116 | |
| Disease | stimulant use measurement | 2.02e-03 | 28 | 70 | 2 | EFO_0600076 | |
| Disease | xanthurenate measurement | 2.16e-03 | 29 | 70 | 2 | EFO_0010551 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 2.31e-03 | 30 | 70 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | response to dolutegravir | 2.31e-03 | 30 | 70 | 2 | EFO_0600017 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLPLLLLLVATTGPV | 11 | Q6UXB8 | |
| GQLLSPPLLLSIFLN | 966 | Q4VNC0 | |
| PLLLLLPQLGIGNAS | 11 | Q8N8R5 | |
| FPPSLGVLVSLQLLL | 1116 | Q9NY47 | |
| LVIPLAILINIGPQT | 61 | P30542 | |
| LISPPLLLSVIFNIL | 966 | Q4VNC1 | |
| PLAPLLALLNNIIEI | 731 | Q32M45 | |
| RLNLLTGLLQFPPEL | 226 | Q96HY7 | |
| LFLNLPLVIGTIPLH | 301 | Q96B67 | |
| LHIAGLRLLNNLPLP | 166 | Q5T9G4 | |
| NLGPSASLQLLLNPL | 336 | Q8IY67 | |
| NNLLLLQQISLPELP | 1301 | P20742 | |
| LPGLKTLVLQNNLIP | 36 | Q6ZNQ3 | |
| NQLLLPLLQGPDITL | 61 | Q9UJX4 | |
| ILLGLTDDPNLQIPL | 11 | A6NL26 | |
| GLTQRPELQLPLFLL | 16 | Q9GZM6 | |
| LDLPGNILIIPQATL | 81 | Q96FN9 | |
| LVEPTLPGLFLLQQL | 261 | Q14667 | |
| LIPLQSGSFALLQLP | 1936 | Q8IWI9 | |
| VLNLVLPNLSLGPID | 166 | Q99685 | |
| LPLLTLSQPLLLGIA | 196 | Q9BRQ3 | |
| RPLSQLALPQVLGLI | 91 | Q8TAC2 | |
| LALPQVLGLILNLPS | 96 | Q8TAC2 | |
| ILLGLTSVPELQIPL | 11 | Q96R09 | |
| LLLLLLLACQPQVPS | 11 | P47871 | |
| VPLLPLLVAGAVLLL | 1641 | Q9UM47 | |
| QLIPQQLLTTLGPLF | 451 | Q71SY5 | |
| SLPPELGQLQNLQIL | 66 | Q5BKY1 | |
| PVQPLSLLLALALRN | 181 | Q2VPB7 | |
| LQLLSNQLLAPPLPD | 2481 | Q9Y4D8 | |
| LPLLLVLALSQGILN | 11 | P17301 | |
| LLLQVLLQEPNPGIE | 291 | Q6ZMM2 | |
| LDCLPQLPQLSLLQL | 1156 | Q86WI3 | |
| LLPENLLVSGLQQIP | 201 | O75161 | |
| LLVSGLQQIPGLLPA | 206 | O75161 | |
| VALPAPLLLTQLPLL | 921 | P29474 | |
| LIPQQLLTTLVPLFR | 306 | Q86YD1 | |
| PRPNPSQLLLLLALL | 301 | Q7RTY9 | |
| VVPALLPLLAGTLLL | 511 | P10696 | |
| LPLILKNNGVLPAQL | 3506 | Q4G0P3 | |
| PSLQAQTVLLLLPLL | 1071 | Q8IZS8 | |
| LQLPQLPLAALQALG | 171 | P23610 | |
| QPLIIPNHLLTLPIL | 251 | A0A1W2PPF3 | |
| LLFLQLPLLGVGLNT | 11 | P31785 | |
| ILINLLLKQPLIPGS | 311 | Q8WXE1 | |
| QALGILLIPPQAQEL | 1501 | A6NE01 | |
| LVAVSPLQLDLQPIL | 636 | O75155 | |
| LLVLLLLLTQPGPIA | 21 | P42830 | |
| GDLLQLPPAVQELLL | 176 | Q9P2P1 | |
| ILLGLTNAPELQVPL | 11 | Q8NGF7 | |
| LLLPELSGPLAVLLQ | 21 | Q8TBP5 | |
| SLVQLQLLPQGPLVQ | 711 | O43196 | |
| QAPLLIALGLLLAAP | 6 | P17900 | |
| LQGLVDPQIQLPLLA | 986 | Q5ST30 | |
| SVLVGLSLLLLPVPL | 746 | Q8NBS3 | |
| LLLLQLLPPSTLSQD | 21 | Q99523 | |
| LTLSLLARQLIPPLN | 111 | Q96RN1 | |
| LQLQLPSALTLLPPS | 601 | Q9NQV8 | |
| VLLSQLPSLLGLSLP | 161 | Q8NG04 | |
| LPLLLLPQQLLQLVQ | 11 | P60153 | |
| FLLLPPGQVSLQQTL | 136 | Q8N5U0 | |
| QRICLPPNLALVLLG | 211 | Q8NBR9 | |
| QLSQLQALALPLTPL | 131 | Q08117 | |
| ALVTPILLQIGLPEQ | 71 | Q5BKX6 | |
| LLPILVPFILLGDIQ | 6 | Q9BQY6 | |
| LAIPQLVGILLSQIL | 246 | Q86UF1 | |
| FLQLILRIPSNILLP | 86 | Q9H081 | |
| QLQVNGVLPILPLLF | 316 | Q12767 | |
| LFLLQQPLAPSGLTL | 36 | Q6NTF9 | |
| SPPLQQLLLPVLLAC | 6 | P47872 | |
| QVPLPQLATGLLLLL | 6 | P35504 | |
| LDLIEPLLQLLPVSN | 381 | Q96DC7 | |
| GFSPLQPGLLLLIIL | 116 | Q8N661 | |
| LILILLEPIPQNSIP | 731 | Q9Y2C9 | |
| LQSLLGLPNPALQAL | 1821 | Q96AY4 | |
| VSLVPTLALLLGLPI | 321 | Q8TEQ8 | |
| IPGLQILNIALPTLI | 2541 | P15822 | |
| NPLLNSLSVLLQDLP | 286 | Q5W0B7 | |
| LLGALQSLLGTQLPP | 121 | P40225 | |
| QVPLPRLATGLLLLL | 6 | P22310 |